Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis

被引:109
作者
Quittner, AL
Sweeny, S
Watrous, M
Munzenberger, P
Bearss, K
Nitza, AG
Fisher, LA
Henry, B
机构
[1] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA
[2] Res Triangle Inst, Res Triangle Pk, NC USA
[3] Genentech Inc, S San Francisco, CA 94080 USA
[4] Wayne State Univ, Detroit, MI 48202 USA
[5] Indiana Univ, Bloomington, IN 47405 USA
[6] Arcos, Arcos, France
关键词
cystic fibrosis; quality of life; methodology; pediatric psychology;
D O I
10.1093/jpepsy/25.6.403
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Objective: To develop a conceptually and semantically valid English version of a French disease-specific measure of quality of life for children, adolescents, and adults with cystic fibrosis (CF). Methods: Following a backward and forward translation of the measure, 60 participants, including 20 children, 20 parents, and 20 adolescents/young adults completed the Cystic Fibrosis Questionnaire (CFQ) and a series of cognitive probes evaluating their understanding of the items and response choices. Results: Semantic and conceptual problems with the items were identified and modified for the second set of cognitive interviews. Response distributions across items and ages were adequate, and the predicted associations between disease severity and quality of life were obtained. Conclusions: The English version of the CFQ appears to be a linguistically valid measure of quality of life for patients with CF. A national validation study is now under way to test the psychometric properties of the measure.
引用
收藏
页码:403 / 414
页数:12
相关论文
共 45 条
[1]   TREATMENT COMPLIANCE IN ADULTS WITH CYSTIC-FIBROSIS [J].
ABBOTT, J ;
DODD, M ;
BILTON, D ;
WEBB, AK .
THORAX, 1994, 49 (02) :115-120
[2]  
Acquadro C, 1996, Quality of life and pharmacoeconomics in clinical trials, P575
[3]  
Andersen R.T., 1996, QUALITY LIFE PHARMAC, V67, P613
[4]  
[Anonymous], 1996, Child Health Questionnaire (CHQ): A User's Manual
[5]  
BRICE TW, 1971, SOC SCI MED, V5, P283
[6]   DEVELOPING AND EVALUATING CROSS-CULTURAL INSTRUMENTS FROM MINIMUM REQUIREMENTS TO OPTIMAL MODELS [J].
BULLINGER, M ;
ANDERSON, R ;
CELLA, D ;
AARONSON, N .
QUALITY OF LIFE RESEARCH, 1993, 2 (06) :451-459
[7]  
Burkovskiy, 1998, APPL WHO QUALITY LIF
[8]  
BUSCHBACH J, 1994, CHEST, V105, P911
[9]  
CAINE N, 1991, TRANSPLANT P, V23, P1203
[10]  
Cella DF, 1996, QUALITY LIFE PHARMAC, P707